At a glance
Our 2023 Performance Overview
182.7 £m See-through Revenue*
31.5 £m Underlying Profit Before Tax*
4.55p Underlying Basic EPS*
180.7 £m Statutory Revenue
-48.8 £m Reported Profit Before Tax
*Non-IFRS Alternative Performance Measures (‘APMs’). See-through revenue includes all sales from Nizoral as if they had been invoiced by Alliance as principal. For statutory accounting purposes the product margin relating to Nizoral sales made on an agency basis is included within Revenue, in line with IFRS 15.
Results centreBuilt for modern business
An inter-connected network of people and brands
A global range of products delivering outstanding value. Many partners working together; one team, achieving more.
Downloads & useful links
2023 Final Results Presentation
DownloadREGULATORY NEWS
- 23 JUL 24 Notification of Major Holdings
- 23 JUL 24 Notification of Major Holdings
- 23 JUL 24 Notification of Major Holdings